Edition:
United Kingdom

Tonix Pharmaceuticals Holding Corp (TNXP.OQ)

TNXP.OQ on NASDAQ Stock Exchange Global Market

0.59USD
16 Oct 2018
Change (% chg)

$-0.00 (-0.79%)
Prev Close
$0.59
Open
$0.62
Day's High
$0.64
Day's Low
$0.57
Volume
113,021
Avg. Vol
113,277
52-wk High
$5.10
52-wk Low
$0.52

Chart for

About

Tonix Pharmaceuticals Holding Corp. is a clinical-stage pharmaceutical company. The Company's drug development programs are directed toward disorders affecting the central nervous system (CNS), and include fibromyalgia (FM), and post-traumatic stress disorder (PTSD). It is focused on developing a portfolio of product candidates,... (more)

Overall

Beta: 2.98
Market Cap(Mil.): $36.27
Shares Outstanding(Mil.): 7.51
Dividend: --
Yield (%): --

Financials

  TNXP.OQ Industry Sector
P/E (TTM): -- 86.20 32.69
EPS (TTM): -6.90 -- --
ROI: -77.69 0.73 14.32
ROE: -77.82 1.82 16.04

BRIEF-Tonix Pharmaceuticals Holding Says Files For Mixed Shelf Of Up To $75 Mln

* TONIX PHARMACEUTICALS HOLDING SAYS FILES FOR MIXED SHELF OF UP TO $75 MILLION - SEC FILING Source text for Eikon: (http://bit.ly/2KqLRZ4) Further company coverage:

01 May 2018

BRIEF-Tonix Pharmaceuticals Receives IND Clearance By U.S. FDA For TNX-102 SL

* TONIX PHARMACEUTICALS RECEIVES IND CLEARANCE BY U.S. FDA FOR TNX-102 SL IN AGITATION IN ALZHEIMER’S DISEASE Source text for Eikon: Further company coverage:

01 May 2018

Competitors

  Price Chg
Johnson & Johnson (JNJ.N) $136.56 +2.61
Pfizer Inc. (PFE.N) $43.93 +0.81
Novartis AG (NOVN.S) CHF84.08 +1.62
AstraZeneca plc (AZN.L) 5,763.00 +144.00
GlaxoSmithKline plc (GSK.L) 1,486.00 +22.40

Earnings vs. Estimates